The “Innovadores” supplement of El Mundo publishes a report on the "Valley of Death" in biolotechnology. This term refers to the phases that between a scientific discovery and it reaching the market.
The article includes comments by experts Delia Zabra, from the Innovation Department at IRB Barcelona, and ICREA researcher Roger Gomis, founder of the spin-off company Inbiomotion.
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to offer pioneering solutions to unresolved medical needs in cancer and other diseases related to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 employees and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).